A judge acquitted
three doctors, a New Jersey company and a former Red
Cross official of criminal charges Monday in a tainted-blood
scandal that infected thousands of Canadians with HIV
or hepatitis and resulted in more than 3,000 deaths.
Ontario superior
court justice Mary Lou Benotto ruled that the defendants
did not show conduct displaying wanton and reckless
disregard in the use of the blood and that there was
no marked departure from the standards of a reasonable
person.
''The conduct
examined in detail over one and a half years confirms
reasonable and responsible and professional actions and
responses during this difficult time,'' she said.
''The allegations of criminal conduct on the part of
these men and this corporation were not only unsupported by
the evidence, they were disproved.
''The events here
were tragic,'' the judge said. ''However, to assign
blame where none exists is to compound the tragedy.''
James Kreppner, a
Toronto lawyer who contracted HIV and hepatitis C from
the tainted blood, said he was astounded.
''It was clearly
negligent behavior and a company violated its statutory
duty, and to call that professional conduct, you just can't
justify that,'' he said.
John Plater of
the Canadian Hemophilia Society expressed bewilderment at
the verdict. ''If you, on the one hand, have a study that
says there's a problem and on the other hand have a
study that says maybe there isn't a problem, any
reasonable person takes the product off the market. They
didn't. People were infected, and people died,'' Plater
said. ''How that could be considered reasonable
behavior is beyond us.''
The case involved
blood products produced by New Jersey-based Armour
Pharmaceutical Co. in the 1980s and early 1990s that turned
out to be infected. Also charged were Roger Perrault
of the Red Cross; John Furesz and Donald Wark Boucher,
formerly of Canada's Health Protection Branch, and
Michael Rodell, a former vice president of Armour.
Perrault pleaded
not guilty to criminal negligence causing bodily harm
for allegedly giving hemophilia patients an HIV-infected
blood-clotting product.
The other doctors
and the drug company also pleaded not guilty. Lawyers
argued that prosecutors didn't present enough evidence to
prove its case.
Defense attorney
Edward Greenspan called it a complete exoneration of his
clients Perrault and Armour Pharmaceutical.
''Canada was
well-served by the people that made these decisions. They
did everything in their power to make the right decision.
They acted upon the information they knew at the
time,'' he said.
A second trial
for Perrault is set to begin later this year in Hamilton,
Ontario, where he will face more criminal charges stemming
from allegations that the Red Cross and its senior
officials failed to take adequate measures to screen
blood donors.
Mina Shah, who
lost her 24-year-old brother Karttik Shah to AIDS and
hepatitis as a result of the tainted blood, said she
couldn't accept the decision.
''She said it was
OK and a great job was done. That doesn't sit well,''
Shah said of the judge's decision. ''There should have been
some sort of punishment.''
The Canadian Red
Cross pleaded guilty in 2005 to distributing blood
tainted with HIV and hepatitis C and was fined 5,000
Canadian dollars, which is now about $5,000 U.S. The
Red Cross apologized and provided 1.5 million Canadian
dollars for a scholarship fund and research project
aimed at reducing medical errors.
Responsibility
for Canada's blood supply for all provinces except Quebec
was later transferred from the Canadian Red Cross to another
entity, Canadian Blood Services. After a five-year
investigation, police filed criminal charges.
Last year the
Canadian government announced a compensation package of
about $1 billion for all those infected with hepatitis C
from the tainted blood, expanding a previous program
that excluded thousands of people. (AP)